drugset / Trial / NCT03014323

Racial Differences in Vagal Control of Glucose Homeostasis, Chronic Study

NCT03014323

RandomizedCrossoverDouble-blindTreatment

Summary

Investigators will test the hypothesis that chronic restoration of vagal nerve activity with a central acetylcholinesterase inhibitor improves insulin sensitivity and reduces adipose tissue oxidation in obese African American Women compared to white women.

Timeline

Start
2017-01
Primary completion
2018-11
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Galantamine Small molecule 4 mg Oral

Indications

No indication recorded.